Agoracom Blog Home

Archive for the ‘Spyder Cannabis Inc.’ Category

8 Small Cap #Cannabis Companies That Will Lead The Next Growth Cycle For The $97 Billion Market By 2026 $AVCN.ca $CBDT.ca $HBOR.ca $HOLL.ca $INNO.ca $SPDR.ca $TBI.ca $TCAN.ca

Posted by AGORACOM-JC at 3:39 PM on Thursday, October 8th, 2020

Despite the collapse of marijuana and cannabis related stocks in the last 18 months, there is no denying that Cannabis related products are going to go through a paradigm shifting, parabolic growth stage around the world over this decade for the following reasons:

  1. Cannabis legalization is gaining momentum around the world.
  2. Momentum is primarily driven by the realization that cannabis may have a range of medicinal, therapeutic and wellness applications.
  3. It is the most widely cultivated, consumed and trafficked drug worldwide (United Nations Office on Drugs and Crime).

So what is this going to translate into?

The global cannabis market size was valued at $US 10.6 Billion in 2018 and is projected to reach $97.5 Billion by the end of 2026, a CAGR of 32.92% (Fortune Business Insights)

WHY WILL THIS TIME BE DIFFERENT?

Big promises, big IR budgets, big hype …. Big Letdown.

That pretty much sums up the last cycle of Cannabis related companies that focused on speed, stories and stock prices rather than the one simple but important thing they should have been doing – building a real business.

Investors will remember that the same thing happened during the dot-com era.  As with the cannabis collapse over the last 18 months, what followed back in 2000 was a long period of mourning in which many investors had sworn off tech stocks, just as they have with cannabis stocks today.

But it wasn’t long until tech investors dusted themselves off and realized tech was here to stay – but this time they were only going to focus on real companies with real businesses.  What we got was Amazon, Google, Linkedin, Facebook and then the rest was history.

The same thing is about to happen to the Cannabis sector

Meet the 8 new horsemen of the next leadership group that are firing on all cylinders (in alphabetical order).

Avicanna (AVCN :TSX) (AVCN : OTCQX) ( 0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.

When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:

1.  The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year.  These are the only known CBD cosmetics backed by clinical trials.

2.  Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain. In addition, the company recently received certification and authorization for the sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia.

3.  Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.

AND… if that is not enough …

4.  Avicanna’s Colombian cultivation division hosts 500,000 Sq ft of low cost and USDA certified organic Cannabis Cultivation. The company recently Made History As The First Ever Export Of Feminized Hemp Seeds From Colombia To The United States. 7,000,000 Seeds For $380,000, with an additional 75,000,000 Seeds Available For Export In Several Pending Transactions.

For more information about the company, please check out the Avicanna HUB on AGORACOM.

Empower (CBDT: CSE) (EPWCF:OTCQB) (8EC:Frankfurt) is a vertically integrated, multi-state operator of medical clinics with a database of over 165,000 patients, a database that almost every medical cannabis and CBD company would kill for … but then these numbers recently came in for the first two quarters to further cement Empower as a leader:

PatientVisits

  • Q1 + 377% To 5,717
  • Q2 + 56% To 6,696

Revenues $USD

  • Q1 + 416% To $790,000 (NO COVID)
  • Q2 + 56% To $923.000

TOTAL Q1 AND Q2

  • REVENUE                 $1.7M vs $745K         = + 130%
  • PATIENTS                 12,400 vs 5,500           = + 125%
  • NET LOSS                 $920K vs 1.85M         = – 50% 

Empower has now delivered growth in 4 successive financial reports (Q4, FY 2019, Q1 and Q2), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019. 

BONUS – The Company’s physician staffed clinics have are also generating significant revenue and growth from the COVID-19 pandemic as follows: 

  • Increased CBD treatments from patients suffering increased anxiety;
  • Testing for individuals and families
  • Testing for local businesses and employees 
  • Testing for enterprise level organizations across the country 
  • Acquisition of an 8,000 sq ft lab in Dallas that can process 4,000 COVID-19 tests per day
    • At the lowest price of $USD 80 per test and operating on just 1,000 tests per day, the clinic would deliver $USD 80,000 in revenue PER DAY

Oh, and did we mention that CEO Steven McAuley is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch? We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never.  Which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth.

For more information about the company, please check out the Empower HUB on AGORACOM.

Harborside (HBOR: CSE), (HSDEF: OTCQX) has generated over $400,000,000 (NOT a typo) since its inception in 2006.  We thought that would get your attention.

What Do They Do?

HBOR is a California-focused, vertically integrated, fully licensed cannabis company with its business consisting of three primary segments:

1. Retail Dispensaries

2. Wholesale

3. Cultivation and Processing

HIGHLIGHTS

  • Founded in 2006. One of the oldest and most respected cannabis retailers in California
  • Awarded one of the first six medical cannabis licenses in the USA
  • Operations have generated over $400M in cumulative sales since inception
  • Retail operations command 3% of California’s entire retail market
  • 2020 Financials (Q1 +  Q2)

○       Revenues         $30,800,000

○       Gross Profit     $14,000,000

○       EBITDA            $1,100,000

  • Expected to generate approximately $62M – $65M in sales in 2020
  • Operate California’s only drive-through dispensary 
  • Over 1,300 customers per day in Q2
  • Oakland dispensary is one of the largest retail cannabis locations in the world
  • 2020E Guidance
    • ~$44M Retail Revenue
    •   ~$21M Wholesale Revenue
    • ~$62M – ~65M Total Revenue

For more information about the company, please check out the Harborside Inc  hub on AGORACOM.

Hollister Biosciences Inc. (HOLL:CSE) (HSTRF:OTC) (HOB: FRANKFURT) is a multi-state cannabis company with products in 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, translating into the following great success:

  • Revenues $USD
    • Q1 +317%  YoY to $862,000
    • Q2 +3685% YoY to  $8,500,000
  • TOTAL Q1 AND Q2
    • REVENUE                 $9.4M vs $428K     = + 2096%
    • GROSS PROFIT        $1.2M vs ($133K)   = + 1002%

In addition to organic sales, Hollister has several high-level partnerships that demonstrate how trusted the Company is within the industry, including:

Hollister is also the creator of California’s most hash-infused pre-roll HashBone

For more information about the company, please check out the Hollister Biosciences Inc. hub on AGORACOM.

Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids.

3 Fully Operating Divisions For Investor Diversification

Innocan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

  1.  PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.
  2. CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.
  3. OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.

Global Manufacturing / Distribution Agreements

  • Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
  • Swiss CBD provider Cloud 9 Switzerland LLC (Distribution – Italy and Switzerland)
  • Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)

Superior Management Team

In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself.  The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:

  • Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
  • Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
  • Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
  • Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.

Together they have built one of the most formidable teams in the small cap cannabis world

For more information about the company, please check out the Innocan Pharma Corporation hub on AGORACOM.

Spyder Cannabis Inc. (SPDR :TSXV) is a Cannabis, Vape and CBD retailer with three retail business units.

  1. SALE OF CANNABIS PRODUCTS – The Company has TWO cannabis dispensaries currently in operation. The first being a location in Calgary, Alberta and the second in Niagara Falls. Both dispensaries are located in busy commercial hubs. The management team is currently evaluating several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint.
  2. SALE OF HEMP CBD (US) Company is also pursuing the sale of Hemp based CBD products from locations in the USA.
  3. SMOKING CESSATION PRODUCTS IN ONTARIO The company sells electronic cigarettes, E-juice and accessories for the “vape” business from five Canadian retail locations; Woodbridge, Scarborough, Pickering, Niagara Falls and Burlington, Ontario. Spyder has established itself as a savvy retailer.

For more information about the company, please check out the Spyder Cannabis  hub on AGORACOM.

Thoughtful Brands, Inc. (TBI: CSE)( 1WZ1: FWB)( PEMTF: OTCQB) is a global natural health products and eCommerce technology company that is operating at full throttle. 

  • Acquired eCommerce retailers with combined total sales of approximately $29,000,000 with an EBITDA of approximately 12.5%.
  • Current customer base of over 200,000 customers with additional leads of over 600,000 potential new customers
  • Enhanced eCommernce solution through Unified Funding’s software which facilitated over $350 million in consumer transactions (CAD $93.8 million) in 2019 from more than one million paying customers.
  •  Low-cost production will be vertically integrated into retail brands to achieve up to 20x margin increase.

We’ll let these revenue numbers speak for themselves.

  • August 2020 CAD $3,809,000
  • July 2020 CAD $2,340,000
  • June 2020 CAD $2,712,000

The above represents an increase of 19%, over the same period in 2019.

QUARTERLY REVENUE $CAD

  • Q1 $7,600,000 Growth
  • Q2  $12,800,000 Growth 

TOTAL Q1 AND Q2

  • REVENUE  $20,400,000
  •  GROSS PROFIT  $2,154,357

The company has its sights set on European expansion through a joint venture with Franchise Cannabis Corp. The company will now sell and market Franchise-manufactured CBD, hemp and cosmetic products in the European Union, Switzerland, Norway and the UK, utilizing its eCommerce platform.

The company also completed acquisition of Verrian, which owns and operates a 110,000-square foot pharmaceutical manufacturing facility in Radebuel, Germany. This acquisition will assist the company in tapping into the burgeoning market for psychedelics as Verrian specializes in developing psychedelic derived medicines for treatments for addictions, including opioids and alcohol.

For more information about the company, please check out the Thoughtful Brands hub on AGORACOM. 

TransCanna (TCAN:CSE) (TH8:FSE) owns a 196,000 square foot cannabis Facility, the largest known fully licensed cannabis facility in California.

  • CAD $24.9M  Revenue Run Rate from 10,000 sq.ft  test facility
  • CAD $90M Annual Revenue expected from first full year of production at Fully Licensed Daly Street Facility.
  • Acquired two California companies,
  • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributer Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented 
  • Direct to dispensary model, cutting out the middleman

 REVENUES  $CAD

  • Q1  $906,000
  • Q2  $4,300,000

 TOTAL Q1 AND Q2

  • REVENUE     $5,206,000    
  • GROSS MARGIN $1,920,000

For more information about the company, please check out the TransCanna hub on AGORACOM.

Thanks for reading and discovering these great small cap cannabis companies.  Please be sure to visit the AGORACOM Small Cap Cannabis Gateway often to stay up to date with new companies at:

https://agoracom.com/portal/Small-Cap-Marijuana-Cannabis-Stocks

Spyder #Cannabis $SPDR.ca Announces Opening of Calgary Cannabis Dispensary $CGC.ca $TLRY $APHA.ca

Posted by AGORACOM-JC at 3:32 PM on Wednesday, September 23rd, 2020
  • Announced that its Calgary Cannabis dispensary located at 140-104 58 Avenue SE, will be open for business effective Saturday, September 26, 2020
  • “The Spyder team is excited to commence operations at its second location and bring its best of class customer service and retail experience to one of Calgary’s busiest commercial hubs,” stated Dan Pelchovitz, the company’s CEO.
  • Company is also currently looking at several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint

Vaughan, Ontario–(September 23, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to announce that its Calgary Cannabis dispensary located at 140-104 58 Avenue SE, will be open for business effective Saturday, September 26, 2020.

“The Spyder team is excited to commence operations at its second location and bring its best of class customer service and retail experience to one of Calgary’s busiest commercial hubs,” stated Dan Pelchovitz, the company’s CEO.

The company is also currently looking at several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

For more information, please contact:
Dan Pelchovitz
905-265-8273

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

Spyder Cannabis $SPDR.ca Announces Final Approvals to Open Niagara Falls and Calgary Cannabis Dispensaries $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:40 AM on Wednesday, July 29th, 2020
  • Announced that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020
  • Also announced that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020

Vaughan, Ontario–(July 29, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to provide the following update:

Niagara Falls and Cannabis Dispensary

The Company is pleased to announce that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020.

Calgary Cannabis Dispensary

The Company is also pleased to announce that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020.

“Both dispensaries are located in busy commercial hubs, in their respective cities. The Spyder team is excited to commence operations and bring its best of class customer service and retail experience to both cities”, stated Dan Pelchovitz, the Company’s CEO.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

For additional info, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]

Spyder Cannabis $SPDR.ca Announces Receipt of RSA (“Retail Store Authorization”) for its Niagara Falls dispensary $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:56 AM on Tuesday, June 30th, 2020
  • Further to the announcement of receipt of a Retail Operator License (“ROL”), the Company is pleased to announce the receipt of its Retail Store Authorization (” RSA”) for its Niagara Falls dispensary located at 6474 Lundy’s Lane
  • The Company plans to begin operations at the location in July once the pre-opening inspection is completed, while ensuring it complies with COVID 19 provincial regulations and focusing on its curbside pickup and delivery business

Vaughan, Ontario–(June 30, 2020) –  Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to provide the following update:

Niagara Falls Cannabis Dispensary

Further to the announcement of receipt of a Retail Operator License (“ROL”), the Company is pleased to announce the receipt of its Retail Store Authorization (” RSA”) for its Niagara Falls dispensary located at 6474 Lundy’s Lane. The Company plans to begin operations at the location in July once the pre-opening inspection is completed, while ensuring it complies with COVID 19 provincial regulations and focusing on its curbside pickup and delivery business.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]

Spyder Cannabis $SPDR.ca Provides Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 12:26 PM on Thursday, June 25th, 2020

Vaughan, Ontario–(June 25, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) provides an update to the filing extension as a result of COVID-19:

Filing Extension of Annual Disclosure Documents Due to COVID-19

Due to circumstances created by the COVID – 19 pandemic it will not be filing its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020 by the scheduled due date of June1, 2020, as required under section 4.4(b) and section 5.1(1) of National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”). Spyder will also not be filing its April 30, 2020 quarterly report and management discussion and analysis which is due June 29, 2020.

As required by Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements (OSC Instrument 51-502), BC Instrument 51-515 Temporary Exemption from Certain Corporate Finance Requirements (BC Instrument 51-515), Blanket Order 51-517 Temporary Exemption from Certain Corporate Finance Requirements (ASC Blanket Order 51-517) and Manitoba Blanket Order 52-502 Temporary Exemption from Certain Corporate Finance Requirements (Manitoba Blanket Order 52-502), the Company discloses the following:

  • The Company’s management and other insiders will be subject to a trading black-out that reflects the principles in Section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders until its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020;
  • The Company expects to file its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020 on or about July 15, 2020 and the quarterly report along with the management discussion and analysis on or about July 31, 2020.

Summary of Recent Developments

On November 12, 2019, the company announced that it completed an acquisition of a development permit issued by the City of Calgary for the operation of a retail cannabis store.

In satisfaction of the purchase of $175,000 Spyder issued 3,000,000 common shares.

On December 20, 2019, the company announced that it’s previous announced Memorandum of Understanding with HighBreed Growth Corp. expired.

On December 23, 2019, the company announced that it had obtained two Development Permits in Calgary, Alberta and received one building permit for one of the locations. Additionally, the company will be submitting an application for a retail cannabis store in the province of Ontario.

On January 10, 2020, the company announced that it had issued 193,846 common shares in consideration for the provision of $12,600 in services provided by AGORA Internet Relations Corp..

On February 3, 2020, the company announced that it has cancelled the previously announced (January 13, 2020) non-brokered private placement of senior secured convertible debentures in the aggregate of $1,500,000. The company was abled to secure a secured bridge loan in the amount of $442,000 primarily by insiders and management.

On May 5, 2020, the company announced that it received a Conditional Cannabis Licence from the City of Alberta.

On May 12, 2020, the company announced that it had received a Cannabis Retail Operator’s Licence (“ROL”) for the Province of Ontario.

The company also previously announced that Mr. Ben Leung was appointed a new board member.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward- looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737

Email: [email protected]

Spyder Cannabis $SPDR.ca Announces Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:17 AM on Tuesday, May 26th, 2020
  • Company is now awaiting receipt of its RSA (“Retail Store Authorization”) for its Niagara Falls dispensary located at 6474 Lundy’s Lane
  • Company is awaiting a final inspection of its dispensary scheduled for the beginning of June, at which point, it intends to begin operations at its Calgary dispensary, located at 104-58th Ave, SE, suite 140
  • In order to address the challenges presented by the COVID 19 crisis, the company has focus on building up the online and e-commerce components for its US Hemp CBD only locations, in Atlantic City and West Palm Beach.

Vaughan, Ontario–(May 26, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to provide the following update:

Niagara Falls Cannabis Dispensary

Further to the announcement of receipt of its ROL (“Retail Operator License”), the company is now awaiting receipt of its RSA (“Retail Store Authorization”) for its Niagara Falls dispensary located at 6474 Lundy’s Lane. The company plans to begin operations at the location as soon as the RSA is issued and final inspection is completed, while ensuring it complies with COVID-19 provincial regulations and focusing on its curbside pickup and delivery business.

Calgary Cannabis Dispensary

Further to the announcement of receipt of its Conditional Cannabis License, the company is awaiting a final inspection of its dispensary scheduled for the beginning of June, at which point, it intends to begin operations at its Calgary dispensary, located at 104-58th Ave, SE, suite 140.

Online and e-Commerce

In order to address the challenges presented by the COVID 19 crisis, the company has focus on building up the online and e-commerce components for its US Hemp CBD only locations, in Atlantic City and West Palm Beach. Specifically, the company has launched a US website as well as an affiliate program to generate increased awareness of the Spyder brand at ShopSPDR.com.

Filing Extension of Annual Disclosure Documents Due to COVID-19

Due to circumstances created by the COVID – 19 pandemic Spyder will not be filing its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020 by the scheduled due date of June 1, 2020, as required under section 4.4(b) and section 5.1(1) of National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”).

As required by Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements (OSC Instrument 51-502), BC Instrument 51-515 Temporary Exemption from Certain Corporate Finance Requirements (BC Instrument 51-515), Blanket Order 51-517 Temporary Exemption from Certain Corporate Finance Requirements (ASC Blanket Order 51-517) and Manitoba Blanket Order 52-502 Temporary Exemption from Certain Corporate Finance Requirements (Manitoba Blanket Order 52-502), the Company discloses the following:

• The Company’s management and other insiders will be subject to a trading black-out that reflects the principles in Section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders until its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020;

• The Company expects to file its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020 on or about July 15, 2020

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

For more information, please contact:

Spyder Cannabis Inc.

Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]

Province of Ontario Issues Spyder Cannabis $SPDR.ca Retail Operator Licence $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-Eric at 8:57 AM on Tuesday, May 12th, 2020

Vaughan, Ontario–(Newsfile Corp. – May 12, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) through its wholly-owned associated applicant, Spyder Cannabis Subco Inc., is pleased to announce that it has received a cannabis retail operator licence from the Alcohol and Gaming Commission of Ontario (the “AGCO”). Spyder has already applied for its Cannabis Retail Store Authorization, located at 6474 Lundy’s Lane, Niagara Falls, Ontario and will operate as SPDR Cannabis. The Retail Store Authorization is the next step required in the process to open its retail operation. Spyder will offer a full assortment of cannabis products from licenced producers.

“The issuance of the Retail Operator’s License is an important milestone in the company’s evolution, and we are excited to commence our growth strategy in the province of Ontario.”, said Daniel Pelchovitz Spyder’s President & CEO.

Spyder would also like to update the previous press release about the Alberta Gaming, Liquor and Cannabis Commission authoriziation. The licence previously announced represents a conditional licence until such time as the final inspection of our already built store is completed and the final licence is given.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of CBD in the United States only, the third is the sale of smoking cessation products in Ontar

Spyder $SPRD.ca Announces Licence to Open #Cannabis Retail Store in Calgary, Alberta $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:42 AM on Tuesday, May 5th, 2020
  • Received a licence from the Alberta Gaming, Liquor and Cannabis commission to open its first store in Calgary, Alberta
  • It is anticipated that the store, located at 104-58th Ave, SE, suite 140 Calgary, Alberta and operate as SPDR Cannabis,
  • Will open in the month of June.

Vaughan, Ontario–(May 5, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to announce that it has received a licence from the Alberta Gaming, Liquor and Cannabis commission (the “AGLC”) to open its first store in Calgary, Alberta. It is anticipated that the store, located at 104-58th Ave, SE, suite 140 Calgary, Alberta and operate as SPDR Cannabis, will open in the month of June. It will offer a full assortment of cannabis products from licenced producers.

“We are excited to open our first licenced cannabis store in Calgary, Alberta, a province which led the way in the rollout of the Canadian cannabis market. The store is ideally located in a busy hub of commercial retail establishments”, said Daniel Pelchovitz Spyder’s President & CEO. “We very much look forward to bringing the Spyder brand and retail experience focus to Calgary”.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward- looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]

Ontario to resume issuing new #cannabis store authorizations – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:03 PM on Friday, April 24th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Ontario to resume issuing new cannabis store authorizations

  • Ontario’s cannabis store regulator will resume issuing new store authorizations for stores that have met regulatory requirements, according to a notice posted to its website today.

The Alcohol and Gaming Commission of Ontario (AGCO) hit pause on new Retail Store Authorizations (RSA) in early April due to emergency measures enacted by the province to fight the COVID-19 pandemic.

New store openings in Ontario are essential to maintaining the growth of Canada’s cannabis industry.

Ontario’s five-dozen cannabis stores put the province far behind Alberta and British Columbia – the provincial leaders in marijuana retail – which have opened 181 and 446 stores, respectively.

Despite that, Ontario’s adult-use cannabis sales rose 3% in February to 38 million Canadian dollars ($27 million), leading Canada.

“Restrictions imposed by the emergency order, including the pause to construction work, have delayed many new retailers in the preparation of their stores. However, the AGCO will resume issuing RSAs to those stores that have met all regulatory requirements,” the Alcohol and Gaming Commission of Ontario said in the statement.

Applying for an Retail Operator License (ROL) is the first step for businesses seeking to open a licensed cannabis store in Ontario. It also determines that store operators meet eligibility criteria.

The next step involves Retail Store Authorization (RSA) applications, which deal with the particulars of a physical cannabis store such as location, layout and security plans.

As of early April, Ontario’s cannabis regulator received nearly 900 Retail Operator License (ROL) applications for marijuana stores since it opened up the process to all comers on Jan. 6.

Ontario previously ordered private cannabis stores to close for two weeks as of April 4 because of the coronavirus. Soon after, the stores were given at least a 14-day window to continue serving customers through curbside pickups and home delivery.

Source: https://mjbizdaily.com/ontario-to-resume-issuing-new-cannabis-store-authorizations/

Cannabis sales spike after lockdown measures in legalised areas – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 12:37 PM on Monday, April 13th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Cannabis sales spike after lockdown measures in legalised areas

  • As more people are confined to their homes, and can’t get out to unwind in other ways, they bought cannabis products at higher rates, and in bigger amounts than they have before

by Sanjana Varghese

Around the world, precautions against the spread of coronavirus have meant that people are confined to their homes for a while. Everyone has their own plans, which has included stockpiling loo roll, food and medicine. 

For people who realise that they may want to relax, those preparations include stockpiling cannabis too – in Canada, the Netherlands, and states in the US where cannabis is legal to buy, the coronavirus lockdown has caused a surge in demand for cannabis products, particularly online and at dispensaries. 

As more people are confined to their homes, and can’t get out to unwind in other ways, they bought cannabis products at higher rates, and in bigger amounts than they have before.

Now that lockdown measures have been in place for several weeks, cannabis companies and other retailers have been able to take stock of how their businesses have fared.

In the middle of March, several marijuana businesses throughout the US saw a spike in people buying all kinds of products. People also tended to be buying it in larger quantities than they would normally.

In California, sales had gone up 159 per cent compared to the sales in March of 2019. 

In general, the legal cannabis industry is a growing one, so there will be more people buying it “officially” than the year before. Even so, the kind of spike that cannabis business owners around the world saw in mid-March coincided exactly with announcements of cannabis lockdowns.  

But is this a good thing? Information from the World Health Organisation suggests that smoking cannabis can weaken the lungs, which isn’t a good thing when we have a global pandemic of a virus which attacks the respiratory system.

However, it seems people may have thought of this.

Data from Headset suggests that while sales of cannabis were up 10 per cent, edibles surged in demand too – by 28 per cent – and that people are shifting away from pre-rolled products when thinking about what they would want to stock up on for a few weeks. 

In Ontario, Canada there were almost 3,000 orders on the last Saturday before full lockdown at the Ontario Cannabis Store. That was an 80 per cent increase over a typical Saturday.  

Daffyd Roderick, the communications director at the OCS, said that they had seen a significant increase in demand for same-day and next day delivery options, in addition to a higher volume of purchases.

Other cannabis stores, in the province of Quebec, also said that they had seen a spike in sales of cannabis over the weekend. Additionally, many shops have started to operate a click and collect service – where people can come and pick up their orders themselves. These kinds of services could offer a chance for people to keep stocked up on the products they want, but they minimise social contact as much as possible. Measures like this are possible in Canada, where individual provinces maintain a monopoly on the sales of cannabis – so they can implement changes more quickly than elsewhere.

In the Netherlands, photos circulated on social media of people in towns and cities lining up to buy cannabis and weed from coffee shops before a government-imposed quarantine would put the country on lockdown. 

While cannabis is illegal in the Netherlands, it is decriminalised for personal use, and posts from social media users showed lines of more than 20 or 30 people waiting to stock up in various cities, from Amsterdam to Utrecht.

The day after the announcement was made, cafes and coffee shops were allowed to re-open as long as they were only offering takeaway services

The situation around cannabis in the US is different from places like Canada and the Netherlands because federal policy governs whether cannabis is legal, as well as whether there are other restrictions on what dispensaries can do with their stock. In eight states that have imposed stay-at-home orders, recreational cannabis can still be sold, and over 15 others have continued to allow the sale of medical cannabis only. 

In states like California and Washington, dispensaries have reported huge increases in demand for their products since mid March.

In Oakland, a dispensary’s whole supply was sold out by 2pm on the day that the lockdown measures were announced.

Delivery services in San Francisco said they had seen an increase in demand for cannabis delivery too, although they weren’t as severe as recent spikes. 

In Pennsylvania, Governor Tom Wolfe declared marijuana dispensaries an essential business, which brought in changes that had otherwise been passing slowly through legislation. Telemedicine – where people are prescribed medication over the phone – mean cannabis has become much more accessible, and for people who needed cannabis to treat illnesses or reduce their symptoms, getting the adequate documentation happened much more quickly too.

Some dispensaries have also transitioned to offering drive-through services too, to minimise contact. 

Other elements of the legal cannabis industry have changed in response to Covid-19. 

The government in Oregon increased the minimum amount of cannabis that you could buy in one go, to stop people from making more trips.

Websites like Leafly, which focus on the world of cannabis, have created guides on disinfecting cannabis product packaging and taking other safety precautions. For business owners, it’s an opportunity to strengthen online vendor systems and figure out whether a drive through system is possible. 

As lockdown measures are extended around the world, cannabis business owners are attempting to figure out what they should be doing next – in some cases, they ordered in extra stock and increased hours for workers. In others, they’ve been encouraging customers to place their orders online, rather than coming into town.

Currently, the length of the lockdown measures remains uncertain, so you might as well be well prepared, whether you’re buying or selling.

Source: https://www.indy100.com/article/coronavirus-cannabis-marijuana-sales-legal-lockdown-9459851